Sign up to receive our free report:
The World's Greatest Investment Ideas:
Buying Discounted Corporate Bonds
E-mail address:

Today, we've got another installment of our popular "World's Greatest Investment Ideas" series. This week's interview is with Porter Stansberry, founder of Stansberry & Associates Investment Research.

We sat down with Porter to discuss one of his favorite investment ideas. It's an idea he says literally changed his investing life, and one he thinks all readers should become familiar with immediately - buying discounted corporate bonds.

We know most investors think buying bonds is about as exciting as watching paint dry, but this idea may surprise you. When Porter says he's found a way to double his money while taking on zero risk, it definitely gets our attention.

You can learn how you can put this idea to work for yourself in this exclusive interview.

Any investor who hopes to safely make a fortune in stocks cannot afford to ignore this idea.

When you sign up for this free report, you'll also receive The Daily Crux Home Delivery.

Each day, the Crux team sifts through the top financial newspapers, magazines, journals, newsletters, blogs, shareholder letters, and research reports. We select only the most valuable news, ideas, and opinions for inclusion on the Crux website. Home Delivery puts it all in your inbox.

No spam pledge: While we'll occasionally send you information about research we think you might be interested in, we will never rent or sell your e-mail address to anyone for any reason.

© 2013 Stansberry & Associates Investment Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This website may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry & Associates Investment Research, LLC. 1217 Saint Paul Street, Baltimore MD 21202.